| Return Reference | Explanation |
|---|---|
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS REVIEWED BY THE TREASURER AND THE CEO PRIOR TO FILING. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE CONFLICT OF INTEREST POLICY COVERS ALL MEMBERS OF THE BOARD, THE OFFICERS, AND STAFF AND IS MONITORED BY ANNUAL WRITTEN INFORMATION QUESTIONNAIRES FROM THE CEO AND SENIOR DIRECTOR, HEAD OF OPERATIONS WHICH ARE REVIEWED AND MAINTAINED BY THE CEO AND SENIOR DIRECTOR, HEAD OF OPERATIONS. THE BOARD OFFICERS REVIEW EACH ISSUE TO COME BEFORE THE BOARD FOR POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. IF ANY POTENTIAL OR ACTUAL CONFLICTS ARE IDENTIFIED THE PERSON DETERMINED TO HAVE A CONFLICT IS RECUSED FROM DELIBERATIONS, VOTING OR ANY ACTIONS RELATED TO THE MATTER. THE IDENTIFIED CONFLICTS WOULD BE DOCUMENTED IN THE MINUTES OF EACH BOARD OR COMMITTEE MEETING IF AN OFFICAL VOTE WAS TAKEN. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE CHAIRMAN OF THE BOARD REVIEWS AND APPROVES THE SALARY FOR THE PRESIDENT. THE PRESIDENT AND CEO REVIEWS AND APPROVES ALL OTHERS WITHIN THE BUDGET. ALL SALARIES WERE APPROVED IN 2025. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE NATIONAL PHARMACEUTICAL COUNCIL DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. |
| Software ID: | |
| Software Version: |